Chinese expert consensus on radiotherapy combined with immunotherapy for unresectable lung cancer (2026 Edition)
Cancer Letters · 2026-10 · 657 · 218719
DOI: 10.1016/j.canlet.2026.218719 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Letters, 2026-10. Verfasst von Linlin Wang und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, Shandong First Medical University Affiliated Cancer Hospital, Jinan, China. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Chemoradiotherapy, Immunotherapy, Lung Neoplasms. Die Arbeit nennt 217 Literaturangaben. Gefördert von: Key Technologies Research and Development Program.
Abstract (Originalsprache)
In recent years, the combination of radiotherapy and immunotherapy has emerged as a major focus of research in the treatment of unresectable lung cancer. With a growing understanding of the synergistic mechanisms between radiotherapy and immunotherapy, together with the accumulation of clinical evidence, this combined approach has demonstrated promising therapeutic potential. Members of the Multidisciplinary Diagnosis and Treatment Committee of the Chinese Anti-Cancer Association, the Radiation Oncology Committee of the Chinese Anti-Cancer Association, the Lung Cancer Committee of the Chinese Anti-Cancer Association, the Small Cell Lung Cancer Expert Committee of the Chinese Society of Clinical Oncology (CSCO), and the Lung Cancer Group of the Respiratory Diseases Branch of the Chinese Medical Association systematically reviewed recent high-quality evidence regarding radiotherapy combined with immunotherapy for unresectable non-small cell lung cancer and small cell lung cancer. Through extensive discussion and multiple rounds of revision, this consensus has been updated from the 2024 version to provide the latest evidence-based recommendations and practical guidance for clinical decision-making.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Radiation Oncology, Shandong First Medical University Affiliated Cancer Hospital, Jinan, China.
- Department of Medical Oncology, Jilin Provincial Cancer Hospital, Changchun, China.
- Department of Respiratory and Critical Care Medicine, Chinese PLA General Hospital, Beijing, China.
- Department of Radiation Oncology, Cancer Hospital, Chinese Academy of Medical Sciences, Beijing, China.
- Department of Medical Oncology, The 5th Medical Center of Chinese PLA General Hospital, Beijing, China.
- Department of Radiation Oncology, Sun Yat-sen University Cancer Center, Guangzhou, China.
Förderung
- Key Technologies Research and Development Program
Zitieren
APA
Wang, L., Liu, Y., Zhao, W., Xing, L., Hui, Z., Liu, X., Chen, M., Wu, Y., Chen, L., Zhou, C., Yu, J., Chairpersons, Vice Chairpersons, Reviewers, Secretaries, & Expert Panel Members (2026). Chinese expert consensus on radiotherapy combined with immunotherapy for unresectable lung cancer (2026 Edition). Cancer Letters, 657, 218719. https://doi.org/10.1016/j.canlet.2026.218719
Vancouver
Wang L, Liu Y, Zhao W, Xing L, Hui Z, Liu X, et al. Chinese expert consensus on radiotherapy combined with immunotherapy for unresectable lung cancer (2026 Edition). Cancer Letters. 2026;657:218719. doi:10.1016/j.canlet.2026.218719
BibTeX
@article{Wang2026,
author = {Wang, Linlin and Liu, Ying and Zhao, Wei and Xing, Ligang and Hui, Zhouguang and Liu, Xiaoqing and Chen, Ming and Wu, Yongzhong and Chen, Liang'an and Zhou, Caicun and Yu, Jinming and Chairpersons, Chairpersons and Vice Chairpersons, Vice Chairpersons and Reviewers, Reviewers and Secretaries, Secretaries and Expert Panel Members, Expert Panel Members},
title = {Chinese expert consensus on radiotherapy combined with immunotherapy for unresectable lung cancer (2026 Edition)},
journal = {Cancer Letters},
year = {2026},
volume = {657},
pages = {218719},
doi = {10.1016/j.canlet.2026.218719}
}
EUVIMED